We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$34.3M
Cap. Flow
-$33.3M
Cap. Flow %
-33.2%
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.08M
2
UNH icon
UnitedHealth
UNH
+$4.05M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.82M
4
NVO
Novo Nordisk
NVO
+$2.52M
5
ABBV icon
AbbVie
ABBV
+$2.39M

Top Sells

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$4.32M
2
HRMY icon
Harmony Biosciences
HRMY
+$3.88M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$3.12M
4
EFC
Ellington Financial
EFC
+$2.6M
5
MTG icon
MGIC Investment
MTG
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 54.58%
2 Real Estate 7.4%
3 Industrials 5.96%
4 Financials 5.87%
5 Technology 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMHY icon
76
iShares JPMorgan EM High Yield Bond ETF
EMHY
$613M
$378K 0.38%
9,956
+555
+6% +$21.4K
SYF icon
77
Synchrony
SYF
$24.8B
$375K 0.37%
5,766
-477
-8% -$29.2K
EMB icon
78
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$375K 0.37%
4,208
+300
+8% +$27.4K
SGRY icon
79
Surgery Partners
SGRY
$2.09B
$374K 0.37%
+17,684
New +$464K
PFF icon
80
iShares Preferred and Income Securities ETF
PFF
$13.3B
$369K 0.37%
11,744
+608
+5% +$19.9K
CWB icon
81
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$367K 0.37%
4,713
-121
-3% -$9.54K
VYM icon
82
Vanguard High Dividend Yield ETF
VYM
$80B
$365K 0.36%
2,858
+43
+2% +$5.61K
AVDL
83
DELISTED
Avadel Pharmaceuticals
AVDL
$354K 0.35%
+33,650
New +$409K
RCAT icon
84
Red Cat Holdings
RCAT
$1.16B
$353K 0.35%
+27,500
New +$168K
REGN icon
85
Regeneron Pharmaceuticals
REGN
$70.9B
$350K 0.35%
+491
New +$412K
AI icon
86
C3.ai
AI
$1.37B
$344K 0.34%
+10,000
New +$310K
MYO icon
87
Myomo
MYO
$36.7M
$322K 0.32%
50,000
– –
IEF icon
88
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$315K 0.31%
3,409
-414
-11% -$39.1K
ACGL icon
89
Arch Capital
ACGL
$35.4B
$315K 0.31%
3,406
-181
-5% -$18.3K
TNDM icon
90
Tandem Diabetes Care
TNDM
$1.17B
$292K 0.29%
+8,105
New +$274K
EWTX icon
91
Edgewise Therapeutics
EWTX
$4.28B
$275K 0.27%
+10,316
New +$328K
PTGX icon
92
Protagonist Therapeutics
PTGX
$9.06B
$275K 0.27%
7,123
-17,877
-72% -$779K
CRL icon
93
Charles River Laboratories
CRL
$10.8B
$272K 0.27%
+1,474
New +$284K
INSM icon
94
Insmed
INSM
$23.5B
$271K 0.27%
3,930
-1,070
-21% -$77.1K
SELF
95
Global Self Storage
SELF
$58.5M
$270K 0.27%
+50,722
New +$259K
APP icon
96
Applovin
APP
$143B
$270K 0.27%
833
-146
-15% -$36.9K
SRPT icon
97
Sarepta Therapeutics
SRPT
$1.82B
$269K 0.27%
2,211
-15,789
-88% -$1.93M
IONS icon
98
Ionis Pharmaceuticals
IONS
$8.99B
$266K 0.27%
+7,614
New +$285K
PCAR icon
99
PACCAR
PCAR
$66.4B
$263K 0.26%
2,530
-239
-9% -$26.2K
APGE icon
100
Apogee Therapeutics
APGE
$10.1B
$256K 0.26%
5,649
-2,851
-34% -$145K
2 3
4
5 6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.

  • AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
  • AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
  • AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
  • AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
  • AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
  • AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.